Advanced Health IntelligenceAHI
13F holders, Q2 2024 (June 30)3holders
0new positions
0sold out
$1.50avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Advanced Health Intelligence (AHI) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Morgan Stanley ($4K), Rhumbline Advisers ($3K) and Qube Research & Technologies Ltd ($57).
- Company
- Advanced Health Intelligence
- CUSIP
- 00777C203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 8 shares bought, net +8 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Morgan Stanley | 0.00% | Add +0.3% | 2,926 | $4K |
| Rhumbline Advisers | 0.00% | No change | 1,965 | $3K |
| Qube Research & Technologies Ltd | 0.00% | No change | 38 | $57 |
"% of holder's portfolio" is AHI's weight in each manager's 13F, not the share of Advanced Health Intelligence the manager owns.